A differential cell capture assay for evaluating antibody interactions with cell surface targets
- 21 February 2010
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 401 (2) , 173-181
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Development of novel humanized anti‐CD20 antibodies based on affinity constant and epitopeCancer Science, 2009
- Individual Blood‐Cell Capture and 2D Organization on MicroarraysSmall, 2009
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- Murine Cell Lines Derived from Pten Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer DevelopmentCancer Research, 2007
- The epitope recognized by rituximabBlood, 2006
- Systems Biology and New Technologies Enable Predictive and Preventative MedicineScience, 2004
- In vivo cancer targeting and imaging with semiconductor quantum dotsNature Biotechnology, 2004
- Detection and Characterizationof Cellular Immune Responses Using Peptide–MHC MicroarraysPLOS Biology, 2003
- Characterization of neurosphere cell phenotypes by flow cytometryCytometry, 2000
- Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.Environmental Health Perspectives, 1997